HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice.

Abstract
Childhood acute myeloid leukemia (AML) is a hematological malignancy in which tumor burden is continuously replenished by leukemic-initiating cells (ICs), which proliferate slowly and are refractory to chemotherapeutic agents. We investigated whether interleukin (IL)-12, an immuno-modulatory cytokine with anti-tumor activity, may target AML blasts (CD45(+)CD33(+)) and populations known to contain leukemia ICs (that is, CD34(+)CD38(-), CD33(+)CD38(+) and CD44(+)CD38(-) cells). We demonstrate for the first time that: i) AML blasts and their CD34(+)CD38(-), CD33(+)CD38(+), CD44(+)CD38(-) subsets express the heterodimeric IL-12 receptor (IL-12R), ii) AML cells injected subcutaneously into NOD/SCID/Il2rg(-/-) (NSG) mice developed a localized tumor mass containing leukemic ICs and blasts that were virtually eliminated by IL-12 treatment, iii) AML cells injected intravenously into NSG mice engrafted within the first month in the spleen, but not in bone marrow or peripheral blood. At this time, IL-12 dramatically dampened AML CD45(+)CD33(+), CD34(+)CD38(-), CD33(+)CD38(+) and CD44(+)CD38(-) populations, only sparing residual CD33(+)CD38(+) cells that did not express IL-12Rβ2. From 30 to 60 days after the initial inoculum, these IL-12-unresponsive cells expanded and metastasized in both control and IL-12-treated NSG mice. Our data indicate that the absence of IL-12Rβ2 in pediatric AML cells favours leukemia progression in NOD/SCID/IL2Rγc-deficient mice.
AuthorsE Ferretti, D Montagna, E Di Carlo, C Cocco, D Ribatti, E Ognio, C Sorrentino, D Lisini, A Bertaina, F Locatelli, V Pistoia, I Airoldi
JournalLeukemia (Leukemia) Vol. 26 Issue 2 Pg. 225-35 (Feb 2012) ISSN: 1476-5551 [Electronic] England
PMID21844875 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD33 protein, human
  • Cd33 protein, mouse
  • Interleukin-12 Receptor beta 2 Subunit
  • Sialic Acid Binding Ig-like Lectin 3
  • ADP-ribosyl Cyclase 1
Topics
  • ADP-ribosyl Cyclase 1 (immunology)
  • Adolescent
  • Adult
  • Animals
  • Antigens, CD (immunology)
  • Antigens, Differentiation, Myelomonocytic (immunology)
  • Cell Division
  • Child
  • Child, Preschool
  • Disease Progression
  • Female
  • Flow Cytometry
  • Humans
  • Infant
  • Interleukin-12 Receptor beta 2 Subunit (metabolism)
  • Leukemia, Myeloid, Acute (immunology, metabolism, pathology)
  • Male
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Real-Time Polymerase Chain Reaction
  • Sialic Acid Binding Ig-like Lectin 3

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: